About this trial
Visual impairment, particularly from glaucoma and retinal dystrophies, significantly hinders mobility and increases the risk of falls, leading to decreased independence and mental health challenges. Current low-vision assistive technologies primarily focus on near-task magnification for reading, leaving a critical gap in tools designed to assist with real-world navigation and peripheral vision loss. To address this, the proposed research evaluates Meta AI glasses, which offer real-time scene narration and object recognition, integrated with the Be My Eyes network. The study hypothesizes that this wearable AI technology will improve ambulation, orientation, and overall quality of life for patients, providing a functional solution for mobility that traditional devices lack.
Eligibility criteria
Qualifiers
Confirmed diagnosis of glaucoma, retinal dystrophy, or another condition associated with legal blindness.
Presence of documented irreversible vision loss
No surgical or laser procedures in the last 6 months
Visual field worse than 12db or poor visual acuity 20/400 or worse
Disqualifiers
Has no access to telephone
Unable to speak English
Has previously received comprehensive low vision services
Trial design
Treatments tested in this trial
- Meta AI Glasses
- Control